Evaluation of the Sub Epidermal Moisture a Device for the Screening of Pressure Ulcer (RELIASEM)

NCT ID: NCT04955106

Last Updated: 2021-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-22

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The device that is the subject of this investigation is a diagnostic tool to detect the among of fluid in hypodermis to help to prevent the formation of pressure injuries. The Sub Epidermal Moister(SEM) Scanner, is a non invasive portable medical device use to complet the clinical jugement of clinician

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The device that is the subject of this investigation is a diagnostic tool to detect the among of fluid in hypodermis to help to prevent the formation of pressure injuries. The Sub Epidermal Moister(SEM) Scanner, is a non invasive portable medical device use to complet the clinical jugement of clinician.

The study "RELIASEM" will study hospitalized patients with high risk of Pressure Injurieswith the next conditions:

For each patient 14 mesures: 6 on the sacrum, 4 on the right heel and 4 on the left heel. This set of measure will be realized 2 timesby 4 different evaluator. To will have been trained in the use of the SEM Scanner where as the other will be novice.

The main objective of this study is to determine on a risk population the intra- and inter-examiner reliability of the SEM Scanner

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preventive Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The SEM Scanner is placed on three skin areas (left heel, right heel and sacrum). It measures the moisture of the subcutaneous tissues. If returns a figure wich induces a classification

* negative = value \<0.6 no risk, the figure is displayed in green
* positive = value ≥0.6 proven risk, the figure is displayed in orange

For each patient 3 measurements will be performed. Two of them will have been trained in the use of the SEM Scanner, whereas the others will be novice
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sample for reliability

Reliability and validity of SEM Scanner : intra rater, inter rater and inter novice/trained 8(2 trained rater, 2 novice rater, each one performed twice)measured will be performed on each patient.

Group Type OTHER

SEM Scanner

Intervention Type DIAGNOSTIC_TEST

They will perform 2 sets of 3 measures (1 on sacrum, 1 on the right heel and 1 on the left heel)for each patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SEM Scanner

They will perform 2 sets of 3 measures (1 on sacrum, 1 on the right heel and 1 on the left heel)for each patients

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged over 18
* Taken the full-hospital care in physical and rehabilitation Medicine
* Patient affiliated with a social security scheme
* In the case of curatorship, patient have read the patient information document and given his consent free and informed, in the presence of his/her curator
* In the case of guardianship, legal representative have to had read the legal representative information document for major placed under legal protection (under guardianship) and given his consent free and informed for the person for whom he is responsible (if the patient is agree),

Exclusion Criteria

* Patient who objected his opposition during the exam
* Patient who have one or more presure ulcer on at list one of the measuring area
* Patient who has had a lower limb amputation
* Pregnant, post natal period or breastfeeding women,
* Person deprived of liberty by judicial or administrative decision
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pôle Saint Hélier

OTHER

Sponsor Role collaborator

Arjo France

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe Gallien, Doctor

Role: PRINCIPAL_INVESTIGATOR

Pôle Saint Hélier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pole Saint-Hélier

Rennes, Brittany Region, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe Gallien, Doctor

Role: CONTACT

+33299295099

Jean-Paul Haeberle

Role: CONTACT

+33626742085

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Philippe GALLIEN, Doctor

Role: primary

+33299295099

JEAN PAUL HAEBERLE

Role: backup

+33626742085

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00458-33

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PMCF Study of Debridement Pad
NCT07255937 RECRUITING NA